Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Visine Advanced Redness + Irritation Relief
- Development stage
- Unknown
- Lead developer
- Kenvue
- Modality
- Small Molecules
- Administration
- Ophthalmic
01
Overview
Visine Advanced Redness + Irritation Relief is an over-the-counter ophthalmic solution marketed by Kenvue. It is a multi-component eye drop designed to alleviate both dryness and redness. The formula contains three lubricants—dextran 70 (0.1%), polyethylene glycol 400 (1%), and povidone (1%)—to moisturize, soothe, and protect the eye surface. These are combined with tetrahydrozoline hydrochloride (0.05%), a small molecule vasoconstrictor that acts as an alpha-adrenergic receptor agonist to reduce redness by constricting blood vessels in the conjunctiva. It is indicated for the relief of eye redness due to minor irritations, protection against further irritation, and the relief of dry eyes.
- Brand names
- Visine Advanced Redness + Irritation Relief
- Other names
- dextran 70 + polyethylene glycol 400 + povidone + tetrahydrozoline hydrochloride
02
Targets
ADRA1A (α1A)
Beyond the preview
Go deeper on Visine Advanced Redness + Irritation Relief.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Visine Advanced Redness + Irritation Relief.